• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. ACRYSOF IQ NATURAL SINGLEPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number SN60WF
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Erythema (1840); Irritation (1941); Pain (1994); Visual Impairment (2138); Discharge (2225)
Event Date 02/13/2017
Event Type  Injury  
Manufacturer Narrative
Evaluation summary: the product was not returned for analysis.The results from the product history record review indicated the product met release criteria.The product investigation could not identify a root cause.There have been no other complaints reported in the lot number.(b)(4).
 
Event Description
A consumer reported that following cataract extraction with an intraocular lens (iol) implant procedure, she experienced worsening of quality of vision, astigmatism, and incorrect splitting of light - she sees light stripes while looking at sun.The surgery was performed approximately 2 months ago.Additional information was provided by the consumer that the day after implantation she had corneal edema.The patient has had atrophia because of inflammation of the optic nerve.After implantation she also experienced eye pain, photophobia.The consumer was using a non- steroidal eye drop and an antibiotic eye drop.She went to the emergency room where she was diagnosed with conjunctival irritation, redness, discharge, and corneal erosion.The ophthalmologist advised the patient to discontinue eye drops.During several visits at various ophthalmologists no specific diagnosis was provided.Astigmatism was stated that was not present prior to the procedure.The patient visited another doctor and started using a non-steroidal eye drop again, together with a steroid drop and a dexapanthenol/polyacrylic polymer combination.Symptoms of splitting of light, redness, and photophobia are continuing.No further information is expected as the consumer does not want doctors to be contacted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ NATURAL SINGLEPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
rita lopez
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514846
MDR Report Key6539034
MDR Text Key74253519
Report Number9612169-2017-00075
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Patient
Type of Report Initial
Report Date 05/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/02/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Model NumberSN60WF
Device Catalogue NumberSN60WF.245
Device Lot Number21176785
Other Device ID Number00380655093283
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received04/07/2017
Date Device Manufactured10/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NEVANAC 1MG/ML; VIGAMOX
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-